This phase 1 clinical trial is a single-center, randomized, placebo-controlled, dose escalation study to evaluate the safety, tolerability, PK, and PD of a single dose of mRNA 1944 in healthy adult subjects.

Cohorts of mRNA-1944 are planned to be investigated in a sequential dose escalation manner.